Loading company…
Prexton Therapeutics develops drugs for Parkinson’s disease and other central nervous system disorders.
Founded in 2012 and based in Geneva, Switzerland, Prexton Therapeutics SA develops drugs for Parkinson’s disease and other central nervous system disorders.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in